F417-0351 Screening compound: ethyl 2-(2-{1-ethyl-4-oxo-4H,5H-[1,2,4]triazolo[4,3-a]quinoxalin-5-yl}acetamido)benzoate

F417-0351 Screening compound: ethyl 2-(2-{1-ethyl-4-oxo-4H,5H-[1,2,4]triazolo[4,3-a]quinoxalin-5-yl}acetamido)benzoate
F417-0351 Screening compound: ethyl 2-(2-{1-ethyl-4-oxo-4H,5H-[1,2,4]triazolo[4,3-a]quinoxalin-5-yl}acetamido)benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound F417-0351
ethyl 2-(2-{1-ethyl-4-oxo-4H,5H-[1,2,4]triazolo[4,3-a]quinoxalin-5-yl}acetamido)benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F417-0351

Molecular Formula

C22H21N5O4 (C22 H21 N5 O4)

Compound Name

ethyl 2-(2-{1-ethyl-4-oxo-4H,5H-[1,2,4]triazolo[4,3-a]quinoxalin-5-yl}acetamido)benzoate

IUPAC name

ethyl 2-(2-{1-ethyl-4-oxo-4H5H-[124]triazolo[43-a]quinoxalin-5-yl}acetamido)benzoate

SMILES

CCc1nnc2n1-c(cccc1)c1N(CC(Nc(cccc1)c1C(OCC)=O)=O)C2=O

InChI

InChI=1S/C22H21N5O4/c1-3-18-24-25-20-21(29)26(16-11-7-8-12-17(16)27(18)20)13-19(28)23-15-10-6-5-9-14(15)22(30)31-4-2/h5-12H,3-4,13H2,1-2H3,(H,23,28)

InChI Key

GXLGJTQJIGZSBV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27126152

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

419.44

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.366

Distribution Coefficient, logD

2.348

Water Solubility, LogSw

-2.97

Polar Surface Area

83.553

Acid Dissociation Constant (pKa)

8.78

Base Dissociation Constant (pKb)

2.92

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

22.70

F417-0351 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F417-0351 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F417-0351?
Check Price and Availability of F417-0351, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F417-0351 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F417-0351
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F417-0351
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F417-0351 available by request